MyFinsight
Home
Blog
About
Back
Income Statement
Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. (ELOX)
source: myfinsight.com
Net loss
-$4,502K
Loss from operations
-$4,450K
Other expense, net
-$52K
Total operating
expenses
$4,450K
Research and development
$2,840K
General and
administrative
$1,610K
Back